FAS and neoplasm: Lymphocytes can directly interact with circulating tumor cells through the FAS-FASL axis or immune-checkpoint molecules, such as PD1-PDL1 and CTLA 4, which will induce immunosuppressive responses, leading to enhanced survival of the tumor cells (43, 44).